REG - Immupharma PLC - Company Secretary Change

ImmuPharmaAnnouncement

07/10/2022 16:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221007:nRSG2369Ca&default-theme=true

RNS Number : 2369C  Immupharma PLC  07 October 2022

 
07 October 2022

ImmuPharma PLC

("ImmuPharma" or the "Company")

 

Appointment of Company Secretary

 

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development
company, is pleased to confirm the appointment of Ward Williams Limited as
Company Secretary to the Company. The appointment is with immediate effect.

 

 

This announcement contains inside information as stipulated under the UK
version of the Market Abuse Regulation no 596/2014 which is part of English
law by virtue of the European (withdrawal) Act 2018, as amended.  On
publication of this announcement via a regulatory information service, this
information is considered to be in the public domain.

 For further information please contact:

ImmuPharma PLC (www.immupharma.com (http://www.immupharma.com) )  +44 (0) 207 206 2650

 Tim McCarthy, Chief Executive Officer

 Lisa Baderoon, Head of Investor Relations                         + 44 (0) 7721 413496

 SPARK Advisory Partners Limited (NOMAD)                           +44 (0) 203 368 3550 (about%3Ablank)

 Neil Baldwin

Notes to Editors

 

About ImmuPharma PLC

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that
discovers and develops peptide-based therapeutics. The Company's portfolio
includes novel peptide therapeutics for autoimmune diseases and
anti-infectives. The lead program, Lupuzor™, is a first-in class autophagy
immunomodulator for the treatment of Lupus and preclinical analysis suggest
therapeutic activity for many other autoimmune diseases that share the same
autophagy mechanism of action.

 

For additional information about ImmuPharma please visit www.immupharma.co.uk

 

ImmuPharma's LEI (Legal Entity Identifier) code: 213800VZKGHXC7VUS895.

 

About Ward Williams Limited

Ward Williams is a leading provider of quality business support and personal
financial services. They differentiate themselves through the range of
services provided. Their client-focused services are delivered through two
divisions: Chartered Accountants and HR Consultants, all working together from
four locations in Weybridge, Uxbridge, Sunninghill and London. For more
information go to: https://www.wardwilliams.co.uk/about-us/
(https://www.wardwilliams.co.uk/about-us/)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  COSUPGGCUUPPGAM